Zerion Pharma
PrivateLast Round
VC Round
Jun 30, 2026
Total Funding Raised
$8.51M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Zerion Pharma operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a VC Round in June 2026.
Zerion Pharma is a pharmaceutical development company that provides a proprietary formulation platform, Dispersome®, to improve the solubility and bioavailability of poorly soluble small-molecule drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zerion Pharma Comparables
Compare Zerion Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| inflamed pharma | 86% | |
| DelAQUA Pharmaceuticals, Inc. | 83% | |
| Intract Pharma | 83% |
For institutional investors. Book with your work email.
Zerion Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 30, 2026 | ||||
| Grant | Jan 12, 2026 | ||||
| Early Funding | May 4, 2023 | ||||
| Early Funding | Dec 14, 2021 | ||||
| Grant | Oct 1, 2020 | ||||
Seed | Jun 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Zerion Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ligand Pharmaceuticals | VC Round |
| Innovation Fund Denmark | Grant |
| Eurostars SME programme | Grant |
| The Export and Investment Fund of Denmark | Early Funding, Seed, Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 173% MoM, reaching 2.8K.
- Jan 12, 2026
$1.4M grant from Eurostars SME programme
For institutional investors. Book with your work email.
Zerion Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Zerion Pharma's valuation, stock price, and market status.
Is Zerion Pharma a public or private company?
Zerion Pharma is a private company.
What is the current stock price of Zerion Pharma?
Zerion Pharma is a private company, so its shares have no public market price. Caplight tracks Zerion Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Zerion Pharma worth (valuation)?
Valuation information for Zerion Pharma is not publicly available.
Can I buy Zerion Pharma stock?
Zerion Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Zerion Pharma's last funding round?
Zerion Pharma's most recent funding round was VC Round on June 30, 2026.
Who are the main investors in Zerion Pharma?
Key investors in Zerion Pharma include Ligand Pharmaceuticals, The Export and Investment Fund of Denmark.
Will Zerion Pharma IPO soon?
No public IPO plans have been announced for Zerion Pharma.
How can I track Zerion Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Zerion Pharma's shares on secondary markets.